- Oscar Health (OSCR) exhibits strong technical momentum, recently setting a new all-time high.
- The stock is up more than 55% over the past year.
- OSCR’s fundamentals are robust. Revenue is projected to grow 60.17% this year, with earnings estimated to rise 203.58%.
- Analyst sentiment is broadly positive, with multiple “Strong Buy” ratings and price targets ranging from $25 to $39.
Today’s Featured Stock
Valued at $10.2 billion, Oscar Health (OSCR) is a digital health insurance company.
What I’m Watching
I found today’s Chart of the Day by using Barchart’s powerful screening functions to sort for stocks with the highest technical buy signals and superior current momentum. I then used Barchart’s Flipcharts feature to review the charts for consistent price appreciation. OSCR checks those boxes. The Trend Seeker issued a new “Buy” signal on Sept. 3. Since then, the stock has lost 2.88%.
Barchart’s Technical Indicators for Oscar Health
Editor’s Note: The technical indicators below are updated live during the session every 20 minutes and can therefore change each day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com website when you read this report. These technical indicators form the Barchart Opinion on a particular stock.
Oscar Health scored a 5-year high of $33.55 on August 24.
- Oscar Health has a Weighted Alpha of 76.44.
- OSCR has a 96% “Buy” opinion from Barchart.
- The stock has gained 55.91% over the past 52 weeks.
- Oscar Health has its Trend Seeker “Buy” signal intact.
- The stock recently traded at $31.33 with a 50-day moving average of $30.51.
- OSCR had 6 new highs and gained12.04% in the last month.
- 60-month beta of 2.37.
- Relative Strength Index (RSI) is at 52.43.
- There’s a technical support level around $31.90.
Don’t Forget the Fundamentals
- $10.2 billion market capitalization.
- 23.04x trailing price-earnings ratio.
- Revenue is projected to grow 60.17% this year and another 8.28% next year.
- Earnings are estimated to increase by 203.58% this year and an additional 7.50% next year.
Analyst and Investor Sentiment on Oscar Health
- The Wall Street analysts followed by Barchart give the stock 3 “Strong Buy,” 1
“Moderate Buy,” 7 “Hold,” and 1 “Moderate Sell” opinion with price targets between $25 and $39. - Value Line does not rate the stock.
- Morningstar thinks the stock is 12% overvalued.
- CFRA’s MarketScope rates the stock as “Strong Buy.”
- 17,560 investors are following the stock on Seeking Alpha, which rates it a “Strong Buy” and rates it the best Life & Health Insurance stock.
- TipRanks’ analysts’ price target is $30.57.
- Short interest is 5.33% of the float with 2.34 days to cover the float.
The Bottom Line on Oscar Health
Insurance companies make their money on investing the float between when they collect the premiums and have to pay out in claims. The investing future looks good for insurers.
Additional disclosure: The Barchart Chart of the Day highlights stocks that are experiencing exceptional current price appreciation. They are not intended to be buy recommendations as these stocks are extremely volatile and speculate should you decide to add one of these stocks to your investment portfolio it is highly suggested you follow a predetermined diversification and moving stop loss discipline that is consistent with your personal investment risk tolerance.
On the date of publication, Jim Van Meerten did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.